Literature DB >> 29945520

Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data.

Grace L Smith1, Prajnan Das1, Joseph M Herman1, Eugene J Koay1, Albert C Koong1, Aaron Grossberg1, Ethan Ludmir1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29945520      PMCID： PMC6093787          DOI： 10.1200/JCO.2018.78.5428

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.

Authors:  Devalkumar J Rajyaguru; Andrew J Borgert; Angela L Smith; Reggie M Thomes; Patrick D Conway; Thorvardur R Halfdanarson; Mark J Truty; A Nicholas Kurup; Ronald S Go
Journal:  J Clin Oncol       Date:  2018-01-12       Impact factor: 44.544

2.  CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.

Authors:  Jia-Wen Zhang; Xiao-Yuan Feng; Han-Qiu Liu; Zhen-Wei Yao; Yan-Mei Yang; Bin Liu; Yong-Qiang Yu
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

3.  The national cancer data base: past, present, and future.

Authors:  David P Winchester; Andrew K Stewart; Jerri Linn Phillips; Elizabeth E Ward
Journal:  Ann Surg Oncol       Date:  2009-10-22       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.